AZD2014
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for AZD2014, covering 2014-06-24 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian [Phase 1]